CVKD
Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. (CVKD) has 8 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 2, 2026.
The most active filer is Chairman and CEO Pham Quang X with 16 filings. Insiders have net sold $283K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Quang X. Pham
- Employees:4
- HQ:Ponte Vedra, FL, US
- IPO:2023-01-20
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$283K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$6.7M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chairman and CEO | Sale | 7,400 | $22K | Jul 2 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 2,127 | $6K | Jun 27 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 9,029 | $28K | Jun 27 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 9,167 | $33K | Jun 24 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 2,277 | $7K | Jun 24 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 3,613 | $11K | Jun 18 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 513 | $2K | Jun 18 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 1,462 | $6K | Jun 16 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 12,996 | $51K | Jun 16 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 3,666 | $13K | Jun 16 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 5,893 | $26K | Jun 11 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 12,992 | $53K | Jun 11 | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 3,500 | $15K | Jun 11 | SEC ↗ | |
| CEO and Chairman | Sale | 303 | $2K | Jun 3 | SEC ↗ | |
| CEO and Chairman | Sale | 349 | $2K | Jun 3 | SEC ↗ | |
Pham Quang XFirst filing | CEO and Chairman | Sale | 1,165 | $7K | May 27 | SEC ↗ |
Related companies
Cadrenal Therapeutics, Inc. is in the Healthcare sector.